Zepsyre . Pascal Besman, Chief Operating Officer of PharmaMar, talks about Submitting Update of Monotherapy to ESMO | Closure of ATLANTIS Trial in Small Cell at ASCO 2018 .

Zepsyre ( Lurbinectedin ) More Pronounced in Overall Survival | OS Endpoint is Preferable from Regulatory POV . By Pascal Besman Chief Operating Officer of PharmaMar .

VHIO tratará linfomas agresivos tipo B con células modificadas genéticamente .